IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.14 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,867,315 | +141.3% | 1,666,766 | +222.4% | 0.00% | +100.0% |
| Q1 2024 | $4,502,748 | -29.5% | 516,963 | -7.4% | 0.00% | -50.0% |
| Q4 2023 | $6,383,829 | -36.5% | 558,027 | -46.6% | 0.00% | -33.3% |
| Q3 2023 | $10,060,663 | -43.3% | 1,044,721 | -37.3% | 0.00% | -40.0% |
| Q2 2023 | $17,735,093 | -4.1% | 1,666,832 | -5.2% | 0.01% | 0.0% |
| Q1 2023 | $18,502,514 | -12.3% | 1,758,794 | +3.3% | 0.01% | -16.7% |
| Q4 2022 | $21,102,772 | +21.6% | 1,703,210 | +1.7% | 0.01% | 0.0% |
| Q3 2022 | $17,358,000 | +24.4% | 1,675,528 | +38.5% | 0.01% | +50.0% |
| Q2 2022 | $13,954,000 | +63.0% | 1,210,200 | +77.8% | 0.00% | +100.0% |
| Q1 2022 | $8,560,000 | -3.7% | 680,466 | -10.7% | 0.00% | 0.0% |
| Q4 2021 | $8,887,000 | -3.0% | 762,182 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $9,159,000 | -0.4% | 701,277 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $9,192,000 | -11.3% | 714,201 | -22.9% | 0.00% | -33.3% |
| Q1 2021 | $10,359,000 | +56.3% | 926,526 | +59.2% | 0.00% | +50.0% |
| Q4 2020 | $6,629,000 | +6.7% | 581,959 | -15.7% | 0.00% | 0.0% |
| Q3 2020 | $6,212,000 | -21.1% | 690,615 | -9.5% | 0.00% | -33.3% |
| Q2 2020 | $7,878,000 | +32.2% | 763,318 | +29.2% | 0.00% | 0.0% |
| Q1 2020 | $5,959,000 | +781.5% | 590,577 | +1063.5% | 0.00% | – |
| Q4 2019 | $676,000 | -88.5% | 50,757 | -92.6% | 0.00% | -100.0% |
| Q3 2019 | $5,876,000 | +3666.7% | 684,378 | +5824.8% | 0.00% | – |
| Q1 2019 | $156,000 | +38.1% | 11,551 | +6.1% | 0.00% | – |
| Q4 2018 | $113,000 | -98.7% | 10,886 | -97.7% | 0.00% | -100.0% |
| Q3 2018 | $8,785,000 | +46.2% | 475,914 | +49.5% | 0.00% | +50.0% |
| Q2 2017 | $6,010,000 | +10086.4% | 318,323 | +6439.1% | 0.00% | – |
| Q2 2015 | $59,000 | +110.7% | 4,868 | +70.3% | 0.00% | – |
| Q2 2013 | $28,000 | – | 2,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $191,107,000 | 16.54% |
| HealthInvest Partners AB | 730,000 | $8,512,000 | 11.99% |
| 13D Management LLC | 612,853 | $7,146,000 | 2.74% |
| Brown Capital Management | 16,257,899 | $189,567,000 | 1.57% |
| BRIDGER MANAGEMENT, LLC | 929,714 | $10,840,000 | 1.40% |
| Camber Capital Management LP | 3,000,000 | $34,980,000 | 1.20% |
| Intrinsic Value Partners, LLC | 55,057 | $642,000 | 0.68% |
| PRICE MICHAEL F | 520,000 | $6,063,000 | 0.67% |
| CLARK ESTATES INC/NY | 355,000 | $4,139,000 | 0.61% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8,145,674 | $94,979,000 | 0.56% |